Series: Immunotherapy for Hematologic Malignancies

Key themes in this series includes improving allogeneic stem cell transplantation outcomes through donor availability and transplant technology, novel cellular therapies including new CAR-Tconstructs, application of checkpoint inhibition, and other new immunotherapeutic targets.

Journal of Clinical Oncology